Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cysteine protease inhibitors described by Senju

March 26, 1997

Sumitomo reveals antipsychotic agents with reduced side effects

March 26, 1997

Dolasetron effective for nausea and vomiting associated with high-dose cisplatin

March 25, 1997

Zeneca granted exclusivity for new formulation of propofol

March 25, 1997

Myotrophin scheduled for review in May

March 25, 1997

Second approval for Zomig

March 25, 1997

Topamax cleared for marketing in Canada

March 25, 1997

AIT-082 enters trials in patients in Canada

March 25, 1997

Dainippon presents broad-spectrum antiemetic agent

March 24, 1997

New advances in Alzheimer's disease treatment, prevention and diagnosis

March 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...